GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Immage Biotherapeutics IMMG · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Immage Biotherapeutics — daily IMMG Delayed
Market value
$15,174
Last close × shares
Volume
1k
Shares, 30 Oct 2026

About Immage Biotherapeutics

Its shares trade under the ticker IMMG. It has been listed since 13 February 2014.

Immage Biotherapeutics Corp. is a biotechnology company, which develops novel immunotherapy biologics to treat various cancers. The company is headquartered in Bethesda, Maryland. The company went IPO on 2014-02-13. The firm is engaged in developing cancer immunotherapy through development of cutting-edge immunotherapy candidates using bioinformatics and outsourced laboratory resources. The company is focused on developing immunotherapy biologics to treat various cancers. The firm develops, markets and licenses its immunotherapy candidate for melanoma-associated antigen-A (MAGE A). The firm plans to focus on the development of immunotherapy for breast and prostate cancer. The firm focuses on developing a fusion/hybrid antigen cancer vaccine that would not only be human leukocyte antigen (HLA) free, but also be effective to all the isomers associated with MAGE A, from 1 to 11, and the identification and development of immunotherapy candidates from its intellectual property library for the preparation for human clinical trials using a viral vector construct.

Figures and description from our data supplier, not checked against the company's own report.

More about Immage Biotherapeutics →

Latest on Immage Biotherapeutics

Our reporting

We have not reported on Immage Biotherapeutics yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Immage Biotherapeutics's ticker?

Immage Biotherapeutics trades as IMMG on its US listing, under ISIN US45250J1007.

What was Immage Biotherapeutics's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.